These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9414020)

  • 21. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury.
    Eisch AJ; Marshall JF
    Synapse; 1998 Dec; 30(4):433-45. PubMed ID: 9826235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of immediate early gene c-fos and zif/268 mRNA expression in rat striatum by metabotropic glutamate receptor.
    Wang JQ
    Brain Res Mol Brain Res; 1998 Jun; 57(1):46-53. PubMed ID: 9630506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic regulation of transcription factor expression in organotypic cultures of developing striatum.
    Liu FC; Takahashi H; McKay RD; Graybiel AM
    J Neurosci; 1995 Mar; 15(3 Pt 2):2367-84. PubMed ID: 7891173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.
    Genova LM; Hyman SE
    Synapse; 1998 Sep; 30(1):71-8. PubMed ID: 9704883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
    Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
    Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phencyclidine induces D-1 dopamine receptor mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons in the rat.
    Griffiths MR; Mitchell IJ; Cooper AJ
    Brain Res; 1999 Mar; 821(1):177-89. PubMed ID: 10064802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamatergic regulation of long-term grafts of fetal lateral ganglionic eminence in a rat model of Huntington's disease.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neurobiol Dis; 2004 Apr; 15(3):648-53. PubMed ID: 15056473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dopamine and NMDA receptors on cocaine-induced Fos expression in the striatum of Fischer rats.
    Sun WL; Zhou L; Hazim R; Quinones-Jenab V; Jenab S
    Brain Res; 2008 Dec; 1243():1-9. PubMed ID: 18822274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function.
    Dall'Olio R; Gaggi R; Bonfante V; Gandolfi O
    Behav Pharmacol; 1999 Feb; 10(1):63-71. PubMed ID: 10780303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S; Krentz L; Moore C; Meshul CK
    Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
    Cook DF; Wirtshafter D
    Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons.
    Dragunow M; Robertson GS; Faull RL; Robertson HA; Jansen K
    Neuroscience; 1990; 37(2):287-94. PubMed ID: 1966822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry.
    Labandeira-Garcia JL; Tobio JP; Guerra MJ
    Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulant-mediated c-fos induction in striatum as a function of age, sex, and prenatal cocaine exposure.
    Snyder-Keller A; Keller RW
    Brain Res; 1998 May; 794(1):88-95. PubMed ID: 9630536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.